PATENT CLAIM ANALYSIS

Application Number: 16074438
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "263310"]

Abstract:
Provided herein is a new mercaptopurine form, as a hemihydrate, and methods of making and using the same.

Claim (Index 18):
The method of  claim 17 , wherein the anticancer agent is methotrexate.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 96.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13606947', '13572367', '15115440', '14429388', '15803538']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6989129143883006
- 35 USC 102 Novelty (BERT): 0.4806312527610037
- Combined Prediction Score: 0.677084748225571
- Mean Citation Score: 145.04095999999996
- Max Citation Score: 150.71388000000005
- Similarity Product: 110.12986849971772

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test